propranolol has been researched along with Nervous System Disorders in 30 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The discovery of propranolol in 1964 and its introducing to the clinical practice has been essential for the progress in the diagnostics and therapy of cardiovascular diseases." | 4.83 | [Propranolol--a place in the modern therapy]. ( Olakowska, E; Olakowski, M, 2006) |
| "The tremor was coarse, irregular, and unrelated to proprioception loss, muscle weakness, or fatigue; it appeared to represent disease activity or an early sign of a new relapse." | 1.27 | Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. ( Dalakas, MC; Engel, WK; Teräväinen, H, 1984) |
| " Although drugs can ameliorate certain toxic effects, indiscriminate use of purported antidotes can have deleterious results." | 1.26 | Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review. ( Irwin, HA; Preskorn, SH, 1982) |
| "While headache was resistant to ergotamine preparations, prompt relief was obtained with propranolol hydrochloride, and adrenergic beta-receptor blocking agent." | 1.25 | Posttraumatic dysautonomic cephalalgia. Clinical observations and treatment. ( Dreyfus, PM; Vijayan, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (80.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 3 (10.00) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lanfranconi, S | 1 |
| Scola, E | 1 |
| Bertani, GA | 1 |
| Zarino, B | 1 |
| Pallini, R | 1 |
| d'Alessandris, G | 1 |
| Mazzon, E | 1 |
| Marino, S | 1 |
| Carriero, MR | 1 |
| Scelzo, E | 1 |
| Faragò, G | 1 |
| Castori, M | 1 |
| Fusco, C | 1 |
| Petracca, A | 1 |
| d'Agruma, L | 1 |
| Tassi, L | 1 |
| d'Orio, P | 1 |
| Lampugnani, MG | 1 |
| Nicolis, EB | 1 |
| Vasamì, A | 1 |
| Novelli, D | 1 |
| Torri, V | 1 |
| Meessen, JMTA | 1 |
| Al-Shahi Salman, R | 1 |
| Dejana, E | 1 |
| Latini, R | 1 |
| Kubo, Y | 1 |
| Sangla, S | 1 |
| Tranchant, C | 1 |
| de Luis, DA | 1 |
| Abad, L | 1 |
| Aller, R | 1 |
| González-Sagrado, M | 1 |
| Dueñas, A | 1 |
| Olakowska, E | 1 |
| Olakowski, M | 1 |
| Furberg, C | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Obukhov, GA | 1 |
| Głuszcz-Zielińska, A | 1 |
| Dalakas, MC | 1 |
| Teräväinen, H | 1 |
| Engel, WK | 1 |
| Preskorn, SH | 1 |
| Irwin, HA | 1 |
| Thandroyen, FT | 1 |
| Asmal, AC | 1 |
| Bhagat, CI | 1 |
| Dayal, B | 1 |
| van Poeck, KJ | 1 |
| Frandsen, PJ | 1 |
| Mikkelsen, B | 1 |
| Vijayan, N | 1 |
| Dreyfus, PM | 1 |
| Bergfeldt, BL | 1 |
| Olofsson, BO | 1 |
| Edhag, KO | 1 |
| Yokoyama, M | 1 |
| Tokue, A | 1 |
| Tsukada, O | 1 |
| Aso, Y | 1 |
| Kerr, JH | 1 |
| Travis, KW | 1 |
| O'Rourke, RA | 1 |
| Sims, JK | 1 |
| Uhl, RR | 1 |
| Nazarova, LN | 1 |
| Petrenko, AD | 1 |
| Kanarek, DJ | 1 |
| Kaufman, B | 1 |
| Zwi, S | 1 |
| Lloyd-Mostyn, R | 1 |
| Watkins, PJ | 1 |
| Oram, S | 1 |
| Conn, RD | 1 |
| Dobrescu, DI | 1 |
| Aigner, A | 1 |
| Baumgartl, P | 1 |
| Bolzano, K | 1 |
| Raas, E | 1 |
| Cherchi, A | 2 |
| Lixi, M | 2 |
| Raffo, M | 2 |
| Porrazzo, G | 2 |
| Bina, M | 1 |
| Camoglio, E | 2 |
| Verona, F | 1 |
| Baszczyński, J | 1 |
| Miyahara, M | 1 |
| Iimura, O | 1 |
| Abe, H | 1 |
| Ueda, T | 1 |
| Morikawa, A | 1 |
| Davis, JN | 1 |
| Frohlich, ED | 1 |
| Tarazi, RC | 1 |
| Dustan, HP | 1 |
| Sassu, P | 1 |
| Biddau, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treat_CCM Clinical Trial A Multicenter Randomized Clinical Trial on Propranolol in Familial Cerebral Cavernous Malformation[NCT03589014] | Phase 2 | 71 participants (Actual) | Interventional | 2018-04-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for propranolol and Nervous System Disorders
| Article | Year |
|---|---|
[Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
Topics: Angiogenesis Inhibitors; Biological Transport; Blood-Brain Barrier; Blood-Retinal Barrier; Cation Tr | 2015 |
[Writer's cramp].
Topics: Botulinum Toxins, Type A; Clonazepam; Combined Modality Therapy; Cumulative Trauma Disorders; Diagno | 2009 |
[Levothyroxine poisoning: clinical manifestations and therapeutic management].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Cardiovascular Diseases; Child; Cholestyramine Resi | 2004 |
[Propranolol--a place in the modern therapy].
Topics: Adrenergic beta-Antagonists; Heart Diseases; Humans; Hyperthyroidism; Nervous System Diseases; Propr | 2006 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Cardiovascular Diseases; Humans; Hyper | 1981 |
3 trials available for propranolol and Nervous System Disorders
| Article | Year |
|---|---|
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Anxiety; Case-Control Studies; Depression; Disease Prog | 2020 |
Propranolol in the treatment of disturbances of the autonomic nervous system.
Topics: Adult; Amobarbital; Atropa belladonna; Autonomic Nervous System; Clinical Trials as Topic; Ergot Alk | 1971 |
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
Topics: Adult; Autonomic Nervous System; Blood Circulation; Blood Pressure; Cardiac Output; Cardiovascular D | 1969 |
21 other studies available for propranolol and Nervous System Disorders
| Article | Year |
|---|---|
Adrenergic beta-blockade and electrocardiographical ST-T changes.
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Electrocardiography; Exercise Test; Humans; Middl | 1967 |
[Use of propranolol and other beta-adrenolytic drugs in the treatment of nervous system diseases].
Topics: Adrenergic beta-Antagonists; Drug Evaluation; Humans; Mental Disorders; Nervous System Diseases; Pro | 1984 |
Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Dysgammaglobulinemia; Humans; Hypergammaglobulinem | 1984 |
Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Child; Dose-Response Relationsh | 1982 |
Autonomic neuropathy in non-insulin-dependent diabetes mellitus in the young.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure; Diabetic Neuropathies; Electrocardiograph | 1980 |
[Chronic recurrent headache without neurological abnormalities. Practice guidelines of the Netherlands Society of Neurology].
Topics: Adult; Aged; Chronic Disease; Contraindications; Drug Interactions; Female; Guidelines as Topic; Hea | 1999 |
[Beta-adrenergic hyperactivity. A new clinical syndrome?].
Topics: Adult; Female; Humans; Isoproterenol; Nervous System Diseases; Propranolol; Receptors, Adrenergic; R | 1978 |
Posttraumatic dysautonomic cephalalgia. Clinical observations and treatment.
Topics: Adult; Autonomic Nervous System; Carotid Artery Injuries; Female; Headache; Humans; Male; Middle Age | 1975 |
Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy.
Topics: Amyloidosis; Atropine; Autonomic Nervous System; Heart Conduction System; Humans; Isoproterenol; Ner | 1985 |
[Hyperdynamic beta-adrenergic circulatory state with markedly labile hypertension (author's transl)].
Topics: Blood Pressure; Female; Humans; Hypertension; Middle Aged; Nervous System Diseases; Propranolol; Rec | 1974 |
Autonomic complications in a case of severe tetanus.
Topics: Aged; Blood Pressure; Central Venous Pressure; Curare; Electric Stimulation; Heart Rate; Humans; Hyp | 1974 |
[Use of inderal for differentiating EKG changes induced by ischemic heart disease and autonomic disorders].
Topics: Adult; Coronary Disease; Diagnosis, Differential; Electrocardiography; Female; Heart Diseases; Human | 1972 |
Severe sympathetic hyperactivity associated with tetanus.
Topics: Adult; Benzyl Compounds; Blood Pressure; Female; Guanidines; Heart Rate; Humans; Nervous System Dise | 1973 |
Proceedings: Autonomic neuropathy and the heart in diabetes.
Topics: Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Output; Denervation; Diabetic Neuropathi | 1974 |
Clinical usefulness of beta-adrenergic blocking agents.
Topics: Administration, Oral; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Cardiomyopathy, Hypert | 1974 |
[Hemodynamic and phonocardiographic changes after propranolol in sympathotonia].
Topics: Adolescent; Adult; Autonomic Nervous System; Blood Pressure; Cardiac Output; Dysautonomia, Familial; | 1970 |
[On the effect of propranolol on the effort electrocardiogram in normal, hypersympathotonic, coronary and pericarditis patients].
Topics: Adolescent; Adult; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Nervous | 1967 |
[Effect of beta adrenergic blockade on the cardiovascular system in the state of sympathicotonia in children].
Topics: Adolescent; Autonomic Nerve Block; Blood Pressure; Child; Electrocardiography; Heart Rate; Humans; N | 1968 |
[A case of hyperdynamic beta-adrenergic circulatory state].
Topics: Adolescent; Cardiovascular System; Humans; Male; Nervous System Diseases; Propranolol; Sympathetic N | 1968 |
Increases beta-receptor responsiveness; central or peripheral?
Topics: Autonomic Nervous System; Cardiovascular Diseases; Chemoreceptor Cells; Hypertension; Isoproterenol; | 1969 |
[On the action of propranolol on the phases of cardiac dynamics in normal, myocardiosclerotic and hypersympathicotonic subjects].
Topics: Adolescent; Adult; Aged; Heart; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Nervous Sys | 1966 |